科学研究

  • 《看不见的敌人》全球流行病...
    2019-06-12
  • 学术报告:Research Progres...
    2019-06-04
  • 学术报告:大气颗粒物及其特...
    2019-05-21

会员登录

用户名:
密码:

2016年度论文动态

Reversing drug resistance of soft tumor-repopulating cells by tumor cell-derived chemotherapeutic microparticles.

Ma J1,2, Zhang Y1, Tang K1,2, Zhang H1, Yin X1, Li Y2, Xu P3, Sun Y2, Ma R2, Ji T2, Chen J3, Zhang S3, Zhang T1, Luo S2, Jin Y4, Luo X5, Li C5, Gong H5, Long Z6, Lu J1, Hu Z7, Cao X1, Wang N3,8, Yang X9, Huang B1,2

Cell Res. 2016 Jun;26(6):713-27. doi: 10.1038/cr.2016.53. Epub 2016 May 10.
PMID: 27167569

Abstract

Developing novel approaches to reverse the drug resistance of tumor-repopulating cells (TRCs) or stem cell-like cancer cells is an urgent clinical need to improve outcomes of cancer patients. Here we show an innovative approach that reverses drug resistance of TRCs using tumor cell-derived microparticles (T-MPs) containing anti-tumor drugs. TRCs, by virtue of being more deformable than differentiated cancer cells, preferentially take up T-MPs that release anti-tumor drugs after entering cells, which in turn lead to death of TRCs. The underlying mechanisms include interfering with drug efflux and promoting nuclear entry of the drugs. Our findings demonstrate the importance of tumor cell softness in uptake of T-MPs and effectiveness of a novel approach in reversing drug resistance of TRCs with promising clinical applications.